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Infection or vaccination confers heightened resis-
tance to pathogen rechallenge because of quantita-
tive and qualitative differences between naive and
primary memory T cells. Herein, we show that
secondary (boosted) memory CD8+ T cells were
better than primary memory CD8+ T cells in control-
ling some, but not all acute infections with diverse
pathogens. However, secondary memory CD8+
T cells were less efficient than an equal number of
primary memory cells at preventing chronic LCMV
infection and are more susceptible to functional
exhaustion. Importantly, localization of memory
CD8+ T cells within lymph nodes, which is reduced
by antigen restimulation, was critical for both viral
control in lymph nodes and for the sustained CD8+
T cell response required to prevent chronic LCMV
infection. Thus, repeated antigen stimulation shapes
memory CD8+ T cell populations to either enhance or
decrease per cell protective immunity in a pathogen-
specific manner, a concept of importance in vaccine
design against specific diseases.
INTRODUCTION
The ability to quickly and specifically eliminate recurring infec-
tions is a hallmark of immunological memory. Thus, the genera-
tion of quality memory CD8+ T cells is an appealing goal for
vaccine design against a variety of infectious diseases (Harty
and Badovinac, 2008; Kaech et al., 2002; Prlic et al., 2007).
Although many studies have demonstrated the enhanced
protective capacity of primary memory CD8+ T cells compared
to naive cells, much less is understood about the function and
properties of memory CD8+ T cells that have been exposed to
additional rounds of antigenic stimulation through either recur-
ring infections or from booster immunizations.
Recent experimental evidence has suggested that antigen
restimulation can dramatically impact both the phenotype and
function of the ensuing memory CD8+ T cell population (Badovi-
nac et al., 2003; Grayson et al., 2002; Jabbari and Harty, 2006;Masopust et al., 2006; Unsoeld and Pircher, 2005). Specifically,
secondary memory CD8+ T cells populations express increased
amounts of Granzyme B, exhibit increased cytolytic activity, and
are more protective than primary memory cells against acute
infection with Listeria monocytogenes (LM) (Jabbari and Harty,
2006). This suggests that additional antigen encounters can
not only increase the overall number of antigen-specific CD8+
T cells, but also result in specific biological changes that impact
the per-cell protective capacity of the memory populations.
However, it is unknown whether antigen restimulation increases
the per-cell protective capacity of memory CD8+ T cells against
pathogens other than LM.
Infection with a pathogenic agent can be broadly defined
as either being acute or chronic. Microbes such as LM, vaccinia
virus (VacV), lymphocytic choriomeningitis virus (LCMV)
Armstrong, and mouse hepatitis virus (MHV) cause acute infec-
tions, in which the pathogen is either eliminated or causes
mortality. In nonlethal infections with these pathogens,
antigen-specific CD8+ T cell numbers peak after clearance
and, after contraction, progress into long-lived primary memory
populations. In contrast, infection with agents that result in
chronic infection, such as LCMV clone 13, causes antigen-
specific CD8+ T cells undergoing a primary response to become
functionally exhausted during the disease course (Wherry et al.,
2007). However, it is currently unknown whether primary or
secondary memory CD8+ T cells are more efficient at controlling
different types of acute or chronic infections. In addition, it is also
unknown whether memory CD8+ T cells exhibit similar charac-
teristics of functional exhaustion compared to naive CD8+
T cells during chronic infection.
Ideally, booster immunizations will result in the generation of
increased numbers of memory CD8+ T cells (Woodland, 2004)
because this number strongly correlates with providing host
protection (Badovinac et al., 2003; Harty and Badovinac, 2008;
Kaech et al., 2002; Schmidt et al., 2008). In contrast to laboratory
animal studies, the ability to reach large numbers of antigen-
specific memory CD8+ T cells in vaccinated humans has proven
difficult (Hill et al., 2010; Masopust, 2009). In addition, a recent
study in our laboratory demonstrated that repeated antigenic
stimulations have a profound impact on the overall gene expres-
sion profile of the ensuingmemory CD8+ T cell populations (Wirth
et al., 2010). Collectively, this suggests that antigen-restimula-
tion-associated changes in memory CD8+ T cell populations
may not always accompany large increases in cell number.Immunity 34, 781–793, May 27, 2011 ª2011 Elsevier Inc. 781
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Modulating Protection by Memory CD8+ T CellsThus, it is critical to determine whether multiple antigen encoun-
ters alter the per-cell protective capacity of memory cell popula-
tions against diverse pathogens because these changes in gene
expression may influence the ‘‘quality,’’ and, therefore, the
‘‘threshold number’’ of memory CD8+ T cells required to provide
host protection (Schmidt et al., 2008).
RESULTS
Secondary Antigen Encounter Impacts Pathogen-
Specific Memory CD8+ T Cell-Mediated Protective
Immunity
Our previous studies using the OT-I CD8+ TCR-tg model demon-
strated that secondary memory CD8+ T cells protect better
against LM expressing ovalbumin (LM-OVA) than primary
memory cells (Jabbari and Harty, 2006). These data raised the
question of whether enhanced protection by secondary memory
CD8+ T cells was universal or specific for certain types of
pathogens or antigens. To address this, we generated primary
and secondary memory P14 TCR-tg CD8+ T cells (specific for
LCMV gp33-41) (Pircher et al., 1989) with adoptive transfers
and LCMV Armstrong infections (Figure S1A). At 60+ days after
infection, both populations of memory cells were analyzed for
expression of a variety of phenotypic markers, cytokine produc-
tion, and sensitivity to antigen (Figures S1B–S1F). Specifically,
primary memory CD8+ T cell populations contained more
CD62Lhi cells and produced more IL-2 than secondary memory
T cells, but both populations were equal producers of IFN-g and
TNF-a. Importantly, using a transfer model of bulk polyclonal
CD8+ T cells and LCMV Armstrong infections, we observed
similar functional characteristics including cytokine production
and sensitivity to antigen in endogenous primary and secondary
polyclonal memory CD8+ T cell populations specific for multiple
LCMV-derived antigens (JCN and JTH, data not shown). Thus,
primary and secondary memory P14 TCR-tg CD8+ T cells reca-
pitulate both the phenotype and functionality observed with
endogenous populations of memory CD8+ T cells.
We next determined whether the enhanced protection by
secondary memory OT-I CD8+ T cells seen against LM-OVA
could be extended to P14 CD8+ T cells and the gp33 epitope
from LCMV. To test this, we purified equal numbers of primary
and secondary memory P14 CD8+ T cells and transferred them
into naive recipients prior to infection with LM-gp33. In agree-
ment with our previous data (Jabbari and Harty, 2006),
secondary memory P14 CD8+ T cells were better than an equal
number of primary memory CD8+ T cells at reducing bacterial
load after LM infection on day 3 postinfection, although both
populations efficiently cleared the pathogen by day 5 (Figures
1A and 1B). To determine whether this finding could be general-
ized, we also compared the protective capacity of memory CD8+
T cells by using three other acute infection models. Indeed,
secondary memory CD8+ T cells were also better at reducing
viral load during a systemic, acute viral infection with LCMV-
Armstrong (Figure 1C) and during an acute lung infection with
VacV-gp33 (Figure 1D). In contrast, primary memory CD8+
T cells protected better during a uniformly lethal infection with
the neurotropic strain of MHV-gp33 on day 7 postinfection (Fig-
ure 1E), suggesting that primary memory CD8+ T cells may be
important for controlling acute infections at later timepoints.782 Immunity 34, 781–793, May 27, 2011 ª2011 Elsevier Inc.These data show that secondary antigen encounter may either
increase or decrease memory CD8+ T cell-mediated protective
immunity during acute infection.
Booster immunizations are often administered to provide
enhanced protection against a number of acute infections in
humans. However, attempts to create a memory CD8+ T cell
population capable of preventing chronic infections, such as
HIV and Hepatitis C Virus, have been less successful (Autran
et al., 2004; Berzofsky et al., 2004; Klenerman and Hill, 2005).
To this end, we next tested whether a second antigen stimula-
tion would also increase the per cell ability of a CD8+ T cell
population to prevent chronic LCMV infection. Naive mice in-
fected with LCMV clone 13 exhibit high viral titers in the spleen
on both day 3 and 10 postinfection, indicative of an established
chronic infection. In agreement with our acute infection models,
secondary memory CD8+ T cells modestly reduced viral levels
in the spleen on day 3 postinfection, whereas primary memory
CD8+ T cells did not (Figure 1F). However, by day 10 postinfec-
tion, primary memory CD8+ T cells completely prevented the
establishment of the chronic infection, whereas an equal
number of secondary memory CD8+ T cells failed to clear the
infection and viral titers in the spleen resembled those of naive
mice receiving no memory CD8+ T cells (Figure 1G). These
data demonstrate that secondary antigenic stimulation de-
creased the per-cell ability of the resulting memory CD8+
T cell population to prevent chronic LCMV infection. Collectively,
these results suggest the intriguing notion that qualitative
changes in the memory CD8+ T cell populations resulting from
repeated antigen stimulation could either improve or limit path-
ogen-specific immunity.
Secondary Memory CD8+ T Cells Become Functionally
Exhausted during Chronic LCMV Infection
The LCMV clone 13 infection model has revealed that chronic
infection profoundly influences the responding T cells in ways
that are also observed in chronic infections of humans
(Day et al., 2006). The effects of chronic infection on a CD8+
T cell population responding to LCMV clone 13 in a previously
naive host include loss of cytokine production (such as TNF-a),
expression of inhibitory receptors, and a dependence on antigen
and proliferation for CD8+ T cell survival (Shin et al., 2007; Shin
and Wherry, 2007; Wherry et al., 2004; Wherry et al., 2003a;
Wherry et al., 2007). Because secondary memory CD8+ T cells
were less efficient than primary memory cells at preventing
chronic LCMV infection, we next analyzed whether this cell pop-
ulation exhibited characteristics of functional exhaustion during
the infection. On day 7 after LCMV clone 13 infection, endoge-
nous CD8+ T cells specific for gp33 and adoptively transferred
naive P14 CD8+ T cells undergoing a primary response exhibited
functional exhaustion, with only 35% of the IFN-g+ population
also producing TNF-a (Figure 2A, top two rows). In contrast,
a large fraction (65%) of primary memory P14 CD8+ T cells
undergoing a secondary response, which cleared the virus
from the spleen by day 10 (Figure 1F), were capable of producing
TNF-a at the same time point (Figure 2A, third row). However,
secondary memory CD8+ T cells undergoing a tertiary response,
which failed to clear the virus, were markedly impaired in TNFa
production (Figure 2A, bottom row). This result demonstrates
that secondary memory CD8+ T cells undergoing a tertiary
Figure 1. SecondaryMemory CD8+ T Cells Provide Better Protection against Infectionswith LM, LCMV-Armstrong, and VacV, but Decreased
Protection against MHV and LCMV Clone 13
(A and B) Naive B6 mice receiving either no cells (None) or 2.53 105 memory P14 TCR-tg CD8+ T cells (primary or secondary) were challenged with 13 105 CFU
of virulent LM-gp33. Bacterial burdens were analyzed in the liver on (A) day 3 or (B) day 5 postinfection.
(C) Same as (A), except that 5.03 105 memory cells were transferred and mice were challenged with 23 105 PFU of LCMV Armstrong. Viral titers were analyzed
in the spleen on day 3 postinfection.
(D) Same as (A), except that 3.0 3 105 memory cells were transferred and mice were infected intranasally with 1 3 107 PFU of VacV-gp33. Viral titers were
analyzed in the lung on day 3 postinfection.
(E) Same as (C), except that mice were infected intranasally with 1 3 105 PFU of MHV-gp33 and titers were analyzed in the brain on day 7 postinfection.
(F and G) Same as (A) except mice were challenged with 2 3 106 PFU of LCMV clone 13. Viral titers were analyzed in the spleen on (F) day 3 and (G) day 10
postinfection. Dashed line indicates limit of detection (LOD). Statistical analyses employed the student’s t test (see also Figure S1).
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Modulating Protection by Memory CD8+ T Cellsresponse become functionally exhausted during early stages of
chronic viral infection.
Along with the loss of cytokine production, exhausted T cells
also exhibit a phenotype that includes molecular indications of
continued antigenic stimulation and increases in inhibitory
receptor expression (Blackburn et al., 2009; Mueller and Ahmed,
2009). Indeed, secondary memory P14 CD8+ T cells undergoing
a tertiary response are impaired in re-expression of CD127 and
continue to express the glycosylated isoform of CD43 (Fig-
ure 2B). In addition, a similarly high percentage of CD8+ T cells
expressing a variety of inhibitory receptors (Blackburn et al.,
2009) including PD-1, LAG-3, 2B4, and CD160 (Figures 2C–2F
and Figure S2A) were observed in tertiary responses compared
with exhausted CD8+ T cells undergoing a primary response. Incontrast, expression of these receptors on CD8+ T cells during
a secondary response is substantially reduced. Collectively,
these data demonstrate that secondary memory CD8+ T cells
display a phenotype of functional exhaustion during a tertiary
response when they fail to prevent chronic LCMV infection.
We next determined whether secondary memory CD8+ T cells
were also more susceptible to functional exhaustion than
primary memory cells when antigen load remained constant.
To test this, we cotransferred a small number of Thy1-disparate
primary and secondary memory P14 CD8+ T cells into naive
animals and subsequently infected them with LCMV clone
13. Importantly, this number of mixed memory CD8+ T cells is
unable to prevent the chronic infection (Figure S2B). In this
scenario, primary memory CD8+ T cells underwent much greaterImmunity 34, 781–793, May 27, 2011 ª2011 Elsevier Inc. 783
Figure 2. Secondary Memory CD8+ T Cells Develop a Unique Phenotype of Functional Exhaustion during Chronic LCMV Infection
(A) Naive mice receiving either no T cells (1 Response, Endogenous), 500 naive P14 CD8+ T cells (1 Response, P14 CD8+), 2.53 105 primary (2 Response, P14
CD8+) or secondary memory P14 CD8+ T cells (3 Response, P14 CD8+) were infected with 2 3 106 PFU of LCMV clone 13. On day 7 postinfection, cells were
obtained from blood of infected animals and stimulated ex vivo with gp33 peptide for 5 hr. IFN-g- and TNF-a-positive cells were identified with intracellular
staining.
(B) Adoptive transfers and infections were performed as in (A). On day 25 postinfection, cells were obtained from spleen and P14 CD8+ T cells, or endogenous
gp33-specfic T cells were analyzed for expression of CD127 and the glycosylated isoform of CD43.
(C–F) Adoptive transfers and infections were performed as in (A). On day 15 postinfection, expression of (C) PD-1, (D) LAG-3, (E) 2B4, and (F) CD160 was analyzed
on the indicated CD8+ T cells in spleen. Representative histograms are shown in Figure S2. For (C)–(F), *p < 0.001 compared to all other groupswith the Student’s t
test.
(G) Same as (A). Mice were then pulsed with BrdU on days 4–7 or 9–13. Representative BrdU incorporation profiles are shown from P14 CD8+ T cells from spleen.
(H) Same as (G), except that expression of Ki67 was assessed on day 7 or 13 postinfection. For (G) and (H), numbers indicate the mean and SD from three
independent mice per group (see also Figure S2).
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Modulating Protection by Memory CD8+ T Cellsexpansion than secondary memory after infection (Figure S2C).
In addition, on day 7 postinfection, the percentage of secondary
memory CD8+ T cells undergoing a tertiary response that were
able to produce IFN-g and TNF-a was substantially lower than
primary memory cells undergoing a secondary response in the
same host (Figures S2D and S2E). However, both populations
became functionally exhausted by day 13 postinfection. High
expression of inhibitory receptors was found on all cell popula-
tions regardless of antigen exposure history (Figures S2F–2I).
Thus, secondary memory CD8+ T cells are inherently more
‘‘exhaustible’’ than primary memory cells.
Secondary Memory CD8+ T Cells Do Not Continue
to Proliferate during Chronic LCMV Infection
Besides displaying increased expression of a variety of inhibitory
receptors and losing the ability to produce cytokines, prior
studies have demonstrated that CD8+ T cells undergoing
a primary response continue to proliferate during the course of
chronic viral infection (Shin et al., 2007; Wherry et al., 2004).
However, it remains unclear whether sustained proliferation is
required for the molecular changes associated with CD8+
T cell exhaustion. During the early stages of LCMV clone 13
infection (days 4–7), all CD8+ T cell populations proliferated, as
demonstrated by BrdU incorporation and Ki67 expression
(a nuclear marker of cellular proliferation) during that time period.
In agreement with previous studies (Shin et al., 2007; Wherry
et al., 2004), both naive endogenous and P14 CD8+ T cells
continued to proliferate during the primary response after the
peak day of expansion (days 9–13) (Figures 2G and 2H). In
contrast, primary memory CD8+ T cells undergoing a secondary
response undergo minimal proliferation during that time frame
because the infection has been cleared in these animals
(Figure 1F). However, secondary memory CD8+ T cells under-
going a tertiary response did not exhibit sustained proliferation
despite failure to clear the chronic infection. Differences in
sustained proliferation of memory CD8+ T cells were also
observed in the same host during established chronic infection
(Figure S2B), in which primary memory CD8+ T cells continue
to proliferate more than secondary memory cells after the peak
of expansion (days 9–13) (Figure S2J). These data demonstrate
that although secondary memory CD8+ T cells display several
signs of becoming functionally exhausted during LCMV clone
13 infection, they do not continue to proliferate. These data
show that CD8+ T cell exhaustion in response to chronic infection
is not intrinsically linked to sustained proliferation.
CD62Lhi Primary and Secondary Memory CD8+ T cells
Both Prevent Chronic LCMV Infection
In order to determine the mechanism(s) by which primary
memory CD8+ T cells are more protective against LCMV clone
13 infection than secondary memory CD8+ T cells, we first
analyzed the proliferative capacity of each memory population.
When memory P14 CD8+ T cells were stimulated directly
ex vivo with gp33 peptide, primary memory CD8+ T cells under-
went more rounds of cell division than secondary memory cells
(Figure 3A). Secondary memory CD8+ T cells produce less IL-2
than primary memory CD8+ T cells, which could impact differ-
ences in TCR-mediated proliferation. However, addition of
excess exogenous IL-2 did not rescue the differences in prolifer-ation observed in the two populations (Figure S3A). In addition,
primary memory CD8+ T cells also underwent greater expansion
than secondary memory CD8+ T cells in response to infections
with LCMV clone 13, LM, and LCMV-Armstrong (Figure 3B and
Figures S3B and S3C). Collectively, these data suggest that
primary memory CD8+ T cells undergo more vigorous prolifera-
tion than secondary memory CD8+ T cells regardless of the
infectious agent. However, in contrast to some previous sugges-
tions (Wherry et al., 2003b), but not others (Huster et al., 2006;
Lauvau et al., 2001), this difference in proliferative potential
does not always translate into providing greater protection by
a memory CD8+ T cell population because secondary memory
CD8+ T cells proliferate less but protect better against acute
infections with LM, LCMV, or VacV (Figure 1).
It has been demonstrated that primary CD62Lhi (central
memory [Tcm]) CD8+ T cells are better than primary CD62Llo
(effector memory [Tem]) cells at clearing LCMV clone 13 (Wherry
et al., 2003b). To test whether the reduced number of CD62hi
cells in the bulk secondary memory population impacted viral
clearance, we purified CD62Lhi and CD62Llo populations of
both primary and secondary memory CD8+ T cells (Figure 3C),
transferred them into naive recipients, and subsequently in-
fected them with LCMV clone 13. CD62Lhi memory cells under-
went robust expansion, regardless of whether they originated
from primary or secondary memory, and were equally efficient
in preventing chronic LCMV infection (Figures 3D and 3E). In
contrast, the CD62Llo populations of both groups expanded
less and failed to prevent the chronic infection. Finally, similar
to what was seen with secondary memory CD8+ T cells, CD62Llo
populations of both primary and secondary memory cells were
impaired in TNF-a production after LCMV clone 13 infection
(Figures 3F and 3G), indicating enhanced susceptibility to
exhaustion. However, this is not an intrinsic characteristic of
the population, as all responding CD8+ T cell populations
efficiently produced TNF-a in response to acute LCMV Arm-
strong infection (Figure 3F). Collectively, these data suggest
that the reduced frequency of CD62Lhi cells in secondary
memory CD8+ T cell populations probably accounted for their
failure to prevent chronic LCMV clone 13 infection.
Memory CD8+ T Cell Localization into Lymph Nodes
Is Required to Prevent Chronic LCMV Infection
It has been argued that primary Tcm cells are more protective
than Tem cells during chronic LCMV infection because of their
increased proliferative capacity (Wherry et al., 2003b). However,
it has not been addressed whether differential trafficking
patterns of these subsets can also impact protective immunity,
given that Tcm cells localize to lymph nodes more efficiently
than Tem cells. To initially determine whether the localization
of memory CD8+ T cells into lymph nodes impacts the ability of
these cells to prevent chronic LCMV infection, we transferred
primary memory P14 CD8+ T cells into WT or Lymphotoxin-
a (Lta)/ mice (which lack lymph nodes) (De Togni et al., 1994)
and subsequently infected themwith LCMV clone 13. As demon-
strated previously, primary memory CD8+ T cells transferred into
WT mice prevent chronic LCMV infection. However, the same
number of primary memory CD8+ T cells transferred into Lta/
mice did not prevent the chronic infection (Figure 4A). In
contrast, both primary and secondary memory CD8+ T cellsImmunity 34, 781–793, May 27, 2011 ª2011 Elsevier Inc. 785
Figure 3. CD62Lhi Memory CD8+ T Cells Are
Equally Protective against Chronic Viral
Infection Regardless of Whether They Are
Primary or Secondary
(A) Two million total splenocytes from mice con-
taining either primary (solid line histogram) or
secondary (dashed line histogram) memory P14
CD8+ T cells were labeled with CFSE and were
incubated with or without gp33 peptide for 60 hr.
Representative CFSE profiles of Thy1.1 memory
P14 CD8+ T cells with and without the addition of
antigen are shown.
(B) A total of 2.5 3 105 primary and secondary
memory P14 CD8+ T cells (Thy1.1) were purified
and adoptively transferred into naive recipients
(Thy1.2), which were subsequently infected with
LCMV clone 13. Kinetics of the secondary or
tertiary CD8+ T cell response were analyzed in the
blood after infection with CD8 and Thy1.1 staining
so that the adoptively transferred population could
be identified. Error bars represent the SD of three
to five mice at each time point.
(C) Analysis of sorted CD62L high (CD62Lhi)- and
low (CD62Llo)-expressing P14 CD8+ T cells from
bulk primary and secondary memory populations.
(D) A total of 1.5 3 105 cells from each of the
groups in (C) were transferred into naive recipients
subsequently infected with LCMV clone 13. Viral
titers were analyzed in the spleen on day 10
postinfection.
(E) Same as (D), except that kinetics of T cell
expansion were monitored over the indicated time
frame with CD8 and Thy1.1 staining so that the
adoptively transferred populations could be iden-
tified. Error bars represent the SD of three samples
for each time point.
(F) Adoptive transfer of memory populations was
performed as in (B), and recipient mice were
subsequently infected with either LCMV clone 13
or LCMV Armstrong. On day 14 postinfection,
TNF-a production by IFN-g+ P14 CD8+ T cells was
assessed with intracellular stain after ex vivo
stimulation with gp33 peptide.
(G) Cumulative data of triplicate samples shown in
(F). Data are representative of two independent
experiments (see also Figure S3).
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Modulating Protection by Memory CD8+ T Cellswere able to decrease bacterial burden in Lta/ mice after LM
infection (Figure 4B). These data demonstrate that lymph
node-deficient Lta/ mice are specifically unable to prevent
chronic LCMV infection, even when a sufficient primary memory
population of CD8+ T cells is present.
Whereas these data suggest that lymph nodes are critical for
memory CD8+ T cell-mediated prevention of chronic LCMV
infection, Lta/ mice also exhibit other biological and anatom-
ical defects including alterations in splenic architecture (Banks
et al., 1995). Tomore directly address whether lymph node local-
ization was specifically required by the memory CD8+ T cell
compartment in order to prevent chronic LCMV infection, we786 Immunity 34, 781–793, May 27, 2011 ª2011 Elsevier Inc.generated primary memory P14 CD8+ T cells that lacked
CD62L (CD62L-deficient) (Xu et al., 1996). At 60 days postinfec-
tion with LCMV-Armstrong, CD62L-deficient P14 CD8+ T cells
exhibited a similar phenotype (other than CD62L expression)
compared to WT cells (Figure S4A). In addition, both WT and
CD62L-deficient cells were equally efficient at producing
IFN-g, TNF-a, and IL-2, underwent similar ex vivo proliferation
in response to gp33 peptide, and expressed equal amounts of
CCR7 (Figures S4B–S4G). However, loss of CD62L dramatically
impaired localization of these cells into lymph nodes, without
affecting distribution into other tissues (Figure 4C and Fig-
ure S4H). Thus, naive CD62L-deficient CD8+ T cells are able to
Figure 4. Lymph Node Homing of Memory CD8+ T Cells Is Required for Prevention of Chronic LCMV Infection
(A) A total of 2.53 105 primary memory P14 TCR-tg CD8+ T cells were transferred into either WT or Lta/mice and subsequently infected with LCMV clone 13.
Viral burden was analyzed from spleens on day 10 postinfection. Data are representative of two independent experiments.
(B) A total of 2.5 3 105 primary or secondary memory P14 CD8+ T cells were transferred into Lta/ mice and subsequently infected with virulent LM-gp33.
Bacterial burden was analyzed in the liver on day 3 postinfection.
(C) Equal numbers (2 3 106) of WT (Thy1.1/1.1) and CD62L-deficient (CD62L-KO) (Thy1.1/1.2) primary memory P14 TCR-tg CD8+ T cells were transferred into
naive (Thy1.2/1.2) recipients. Forty-eight hours later, organ-specific localization of both cell populations was determined. Representative histograms are shown
in Figure S4H (ILN, inguinal lymph node; CLN, cervical lymph node).
(D and E) A total of 2.5 3 105 WT or CD62L-deficient primary memory P14 CD8+ T cells were purified and transferred into naive recipients and subsequently
infected with virulent LM-gp33. Bacterial burden was measured in the (D) spleen and (E) liver on day 3 postinfection.
(F) Same as (D and E) except mice were infected with LCMV clone 13, and viral burden was analyzed in the spleen on day 10 postinfection (see also Figure S4).
Statistical analyses were performed with the Student’s T test.
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Modulating Protection by Memory CD8+ T Cellsbecome functional memory cells after LCMV-Armstrong infec-
tion, although their ability to localize into lymph nodes is dramat-
ically impaired.
Because CD62L is required for efficient lymph node localiza-
tion (Arbone´s et al., 1994; Catalina et al., 1996; Steeber et al.,
1996), we next determined whether expression of CD62L
provided any benefit to primary memory CD8+ T cell populations
with regards to protective immunity during both acute and
chronic infections. To test this, we transferred equal numbers
of both WT and CD62L-deficient primary memory P14 CD8+
T cells into naive recipients and subsequently infected them
with LM-gp33. WT and CD62L-deficient primary memory CD8+
T cells provided equal protection against LM (Figures 4D and
4E), demonstrating that CD62L on memory CD8+ T cells does
not impact their ability to protect against this acute infection. In
contrast, CD62L-deficient primary memory CD8+ T cells failed
to prevent chronic LCMV infection compared to an equal numberof WT cells (Figure 4F). Thus, expression of CD62L on primary
memory CD8+ T cells and the ensuing ability to enter lymph no-
des directly impacts the ability of these cells to prevent chronic
LCMV infection.
Lymph Node Primed Memory CD8+ T cells Are Required
to Prevent Chronic LCMV Infection
To determine mechanistically why lymph node localization is
required to prevent chronic LCMV infection, we first analyzed
organ-specific activation of both WT and CD62L-deficient
primary memory CD8+ T cells after LCMV clone 13 infection.
On day 3 postinfection, equal numbers of both cell populations
could be found in the spleen and expressed similar levels of
the early activation markers CD25 and CD69 (Figures 5A–5C).
In contrast, CD62L-deficient cells could not be found in the
lymph nodes at this time point, whereas activated WT cells
were readily detected. Furthermore, by day 7 postinfection,Immunity 34, 781–793, May 27, 2011 ª2011 Elsevier Inc. 787
Figure 5. CD62L-Deficient Primary Memory CD8+
T Cells Become Activated in the Spleen after
LCMV Clone 13 Infection, but Become Functionally
Exhausted
(A and B) A total of 2.5 3 105 WT or CD62L-deficient
(CD62L-KO) primary memory P14 TCR-tg CD8+ T cells
were transferred into naive B6 mice and subsequently
infected with LCMV clone 13. Total numbers of P14 CD8+
T cells were determined in the (A) spleen or (B) inguinal
lymph node on day 3 postinfection.
(C) P14 CD8+ T cells from (A) were analyzed for expression
of CD25 and CD69; ND, none detected.
(D) Adoptive transfers and infection was performed as in
(A). On day 7 postinfection, cells were obtained from blood
of infected animals and stimulated ex vivo with gp33
peptide for 5 hr. IFN-g- and TNF-a-positive cells were
identified with intracellular staining. Data are representa-
tive of two independent experiments.
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Modulating Protection by Memory CD8+ T CellsCD62L-deficient memory CD8+ T cells in the spleen became
functionally exhausted and produced less TNF-a than WT cells
(Figure 5D). Thus, these data suggest that activation of memory
CD8+ T cells in lymph nodes is required for the prevention of
chronic LCMV infection. Furthermore, WT primary memory
CD8+ T cells underwent dramatic expansion in lymph nodes after
LCMV clone 13 infection (Figure 6A), which also resulted in
decreased viral burden in the lymph node (Figure 6B). In addition,
responding WT memory CD8+ T cells produced significantly
more TNF-a than CD62L-deficient cells that emigrated into the
lymph node and became detectable on day 7 after infection
(Figures 6C and 6D). Therefore, these data demonstrate that
activation and expansion of memory CD8+ T cells in the lymph
nodes results in both decreased viral burden and generation of
‘‘quality’’ effector cells after LCMV clone 13 infection.
The robust expansion of WT primary memory CD8+ T cells in
the lymph node after LCMV clone 13 infection suggested that
once activated, these cells may play an important role in
combating the systemic infection. To test this, we cotransferred
equal numbers of WT and CD62L-deficient primary memory
CD8+ T cells and infected recipient mice with LM, LCMV
Armstrong, or LCMV clone 13 (Figure 6E). During early time
points (day 5) after all infections, more CD62L-deficient than
WT T cells could be found in the blood, further demonstrating
that early activation and proliferation of CD62L-deficientmemory
T cells were not impaired. After LCMVArmstrong or LM infection,
the representation of each population remained constant until
day 10 postinfection. However, by day 10 postinfection with
LCMV clone 13, nearly all of the detectable cells in the blood
were WT (Figure 6E). These data show that the impaired lymph
node localization of CD62L-deficient primary memory T cells
prevented a sustained response from this population after
LCMV clone 13 infection. This suggests that in addition to
impaired viral clearance in lymph nodes, the inability of CD62L-
deficient memory CD8+ T cells to prevent chronic LCMV infec-
tion also resulted from the lack of a lymph node-dependent
sustained CD8+ T cell response.
To further evaluate the requirement for egress of lymph node
primed memory CD8+ T cells to prevent chronic LCMV infection,
we utilized the sphingosine-1-phosphate receptor agonist
FTY720, which inhibits T cell egress from lymph nodes (Brink-
mann et al., 2002; Matloubian et al., 2004). Indeed, after LCMV
clone 13 infection of mice seeded with primary memory P14
cells, treatment with FTY720 caused an accumulation of acti-
vated memory CD8+ T cells within lymph nodes and decreased
numbers in both the spleen and blood (Figures 7A–7C and
Figure S5). Importantly, FTY720-mediated trapping of respond-
ing primary memory CD8+ T cells in the lymph node also
impaired clearance of LCMV clone 13 (Figure 7D). Although the
effect of FTY720 treatment on viral clearance in mice harboring
primary memory CD8+ T cells was not absolute, these data
demonstrate that altering the capacity of re-activated memory
CD8+ T cells to leave lymph nodes can dramatically impact their
ability to prevent chronic viral infection. Collectively, these data
suggest that memory CD8+ T cell entry into lymph nodes, activa-
tion, expansion, and subsequent egress are required for the
sustained CD8+ T cell response necessary to prevent chronic
infection with LCMV clone 13. Thus, the altered tissue localiza-
tion of either CD62L-deficient primary or of boosted secondarymemory CD8+ T cells directly impacts the per-cell protective
capacity of these populations against a specific pathogen.
DISCUSSION
Although a great deal of effort has been dedicated to the
understanding of the factors and mechanisms that ultimately
lead to the generation of primary memory CD8+ T cells, much
less is known about memory CD8+ T cell populations that are
generated after additional antigen restimulations. Herein, we
demonstrate that antigen restimulation increases the ability for
a memory CD8+ T cell population to protect against acute infec-
tions with several pathogens. However, antigen restimulation
decreases the per-cell ability of memory CD8+ T cells to protect
against acute, lethal MHV infection and to prevent chronic LCMV
infection. Because the model of chronic LCMV infection has
provided a wealth of knowledge to the field of experimental
immunology, we went on to delineate the individual factors
that contribute to both the ability for primary memory CD8+
T cells to effectively control the infection and those that
contribute to the impaired protection by secondary memory
CD8+ T cells.
Previous studies report that re-expression of CD62L is de-
layed in memory populations generated by multiple antigen
encounters (Jabbari and Harty, 2006; Masopust et al., 2006).
However, because expression of this molecule also tracks with
the differentiation state of primary memory CD8+ T cells
(Tcm versus Tem cells), it was unknown whether localization
alone or other genetic factors associated with the specific
differentiation state were the driving force behind the ability for
Tcm cells to efficiently prevent chronic LCMV infection (Wherry
et al., 2003b). We show that CD62L-deficient primary memory
CD8+ T cells are similar to WT cells with regards to function,
phenotype, and ability to protect against virulent LM infection.
However, genetic ablation of this single molecule specifically
inhibits memory CD8+ T cell distribution into lymph nodes, but
not to other tissues of the body. Therefore, our data strongly
argue that, from a mechanistic standpoint, CD62L-dependent
lymph node localization of memory CD8+ T cells is critical for
maximum defense (both viral control in lymph nodes and
sustained recall response) against chronic LCMV infection.
In this report, we also identify three key aspects of memory
CD8+ T cell biology that change after a subsequent antigen
encounter that impair their ability to prevent chronic LCMV infec-
tion. First, on a population level, secondary memory CD8+ T cells
not only become ‘‘exhausted’’ during chronic LCMV infection,
but are inherently more ‘‘exhaustible’’ than a primary memory
population. Second, the ability to mount a robust recall response
is diminished in secondary memory CD8+ T cells. Third, the
ability to localize to lymph nodes decreases in secondary
memory cells due to delayed re-expression of CD62L. Although
we provide substantial, additional evidence that lymph node
localization is critical for conferring host protection against
chronic LCMV infection, this finding is complicated by the fact
that hundreds of genes are differentially regulated between
primary and secondary memory CD8+ T cells (Wirth et al.,
2010). Thus, it is highly likely that several linked mechanisms
act in concert to cause the overall failure of secondary memory
CD8+ T cells to prevent chronic LCMV infection.Immunity 34, 781–793, May 27, 2011 ª2011 Elsevier Inc. 789
Figure 6. Lymph Node Localization of
Memory CD8+ T Cells Results in Enhanced
Viral Clearance and Sustained Effector
Response during LCMV Clone 13 Infection
(A) A total of 2.0 3 105 WT or CD62L-deficient
(CD62L-KO) primary memory CD8+ T cells were
transferred into naive recipients and subsequently
infected with LCMV clone 13. On days 3, 5, and 7,
the total number of transferred cells was quantified
in the inguinal lymph nodes.
(B) Viral burden in the inguinal lymph node from (A)
was determined on day 5 postinfection.
(C and D) Same as (A), except that on day 7
postinfection, lymph node cells were stimulated
with gp33 peptide and TNF-a production was
analyzed on IFN-g+ cells with intracellular staining.
(E) Equal numbers (1 3 104) of WT (Thy1.1/1.2) or
CD62L-deficient (Thy1.1/1.1) primarymemory P14
TCR-tg CD8+ T cells were transferred into naive B6
mice and subsequently infected with virulent LM-
gp33, LCMV-Armstrong, or LCMV clone 13. On
days 5, 6, 7, and 10, representation of each cell
population was determined in the blood with
Thy1.1 and Thy1.2 staining. Representative
histograms from days 5 and 10 show percentages
of CD62L-deficient (Thy1.2-negative) and WT
(Thy1.2-positive) P14 CD8+ T cells. Dashed line
indicates input ratio. Error bars represent the SD of
individual samples at each time point, statistical
analyses were performed with the Student’s T
test, and data are representative of two indepen-
dent experiments with three mice per group.
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Figure 7. Blocking Activated Memory CD8+ T Cell Egress from Lymph Nodes after LCMV Clone 13 Infection Results in Impaired
Viral Clearance
(A–C) A total of 1.53 105 primarymemory P14 TCR-tg CD8+ T cells were transferred into naive B6mice and subsequently infectedwith LCMV clone 13.Micewere
then treated with FTY720 or vehicle control on days 0, 2, and 4 postinfection. On day 6 postinfection, numbers of P14 CD8+ T cells were determined in the (A)
blood, (B) spleen, or (C) inguinal lymph node. Representative dot plots for each organ are shown in Figure S7. For (A)–(C), error bars represent the SD and
statistical analysis was performed with the Student’s t test. Data are representative of two independent experiments with five mice per group.
(D) Same as (A), except that mice were treated with FTY720 or vehicle control on days 0, 2, 4, 6, and 8 postinfection. On day 10 postinfection, viral burden from
individual mice was determined in the spleens of infected animals. Cumulative data from two independent experiments are shown (see also Figure S5).
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prevention of a variety of acute infections (de Quadros, 2002). In
these cases, the establishment of a sufficient memory immune
repertoire limits pathogen spread and replication, and elimina-
tion of the infectious agent occurs without onset of severe
disease symptoms. However, vaccines against infectious
agents that cause persistent or chronic infections have been
far less successful (Berzofsky et al., 2004). Chronic viral infec-
tions are a major cause of not only a number of human diseases
(HIV, hepatitis C virus), but are also thought to contribute to the
development of a variety of human cancers (EBV—B cell
lymphomas, human papillomavirus virus—cervical cancer). In
virtually all these cases, failure to completely eliminate the path-
ogen leads to the generation of CD8+ T cells that are functionally
exhausted. In fact, it has been demonstrated that human CD8+
T cells specific for antigens of HIV, EBV, and CMV express inhib-
itory receptors and are CD62Llo (Chen et al., 2001; Day et al.,
2006). However, other aspects of pathogen biology, such as
rapid mutation, also probably contribute to the establishment
of chronic infection in humans. In addition, our data also suggest
that the duration of antigen or pathogen load during infection
(such as in MHV and chronic LCMV infection) may also be
a determining factor as to which type of memory CD8+ T cell
population is most protective. Although it is unclear whether
entry into lymph nodes will be an essential feature of protective
CD8+ T cells against all chronic infections, it is possible that
driving memory CD8+ T cells away from lymph nodes through
repeated antigen encounters may be advantageous to the
persistence of these types of pathogens. Clearly, the ‘‘best’’
memory CD8+ T cell population is going to vary from pathogen
to pathogen, dependent upon variables including the site of
infection, microbial persistence, and cellular targets of the
pathogen.
In conclusion, our data demonstrate that booster immuniza-
tions may not only increase the overall number of memory
CD8+ T cells, but also leads to biologically relevant functional
alterations that can either increase or decrease the per-cellprotective capacity of the memory cell population for specific
pathogens. Because vaccines against chronic infections have
been difficult to develop, these data provide direct evidence
that both the quality and quantity of a memory CD8+ T cell pop-
ulation must be taken into account when developing vaccination
strategies that are able to prevent specific diseases.EXPERIMENTAL PROCEDURES
Mice and Pathogens
C57BL/6 mice (Thy1.2) were obtained form the National Cancer Institute and
used for experiments at 6–10 weeks of age. P14 transgenic mice (Thy1.1)
(Pircher et al., 1989) were provided by M. Bevan and B6.PL (Thy1.1) were ob-
tained from Jackson Laboratories and maintained by sibling 3 sibling mating.
Lymphotoxin-a (Lta)-deficient mice (De Togni et al., 1994) and CD62L
(Sell)-deficient mice (Xu et al., 1996) have been previously described. LCMV
Armstrong and LCMV clone 13 were propagated according to standard proto-
cols. LCMV Armstrong (2 3 105 PFU) was injected i.p. as indicated. LCMV
clone 13 (2 3 106 PFU) was injected i.v. Vaccinia virus expressing full-length
LCMV glycoprotein (VacV-gp) was kindly provided by E. Butz and was propa-
gated in accordance to standard protocols. VV-gp was given intranasally in
40 ml of saline. Virulent Listeria monocytogenes expressing gp33 (LM-gp33)
(Kaech and Ahmed, 2001) was grown and injected i.v. Recombinant MHV
expressing gp33 (Kim and Perlman, 2003) was kindly provided by S. Perlman
and was given intranasally. All animal experiments followed approved Institu-
tional Animal Care and Use Committee protocols.
Cell Purification and Adoptive Transfer
For generation of primary memory P14 CD8+ T cells, naive Thy1.1 P14 CD8+
T cells (5 3 103) were obtained from peripheral blood and were injected i.v.
into naive Thy1.2 WT recipients. Mice were infected 24 hr later with 2 3 105
PFU of LCMV-Armstrong i.p. For generating secondary memory P14 CD8+
T cells, total splenocytes from mice containing primary memory were stained
with PE-anti-Thy1.1 antibody (Clone OX-7, BD PharMingen) and purified with
anti-PE magnetic bead sorting with standard AutoMacs protocols. After
purification, primary memory Thy1.1 P14 CD8+ T cells (5 3 104) were injected
i.v. into naive Thy1.2 recipients and the recipients were infected 24 hr later with
LCMV-Armstrong i.p. Primary and secondary memory P14 CD8+ T cell popu-
lations were used at the same time point (60+ days) after LCMV-Armstrong
infection. For sorting of CD62L high and low expressing cells, memory P14
CD8+ T cells were purified with magnetic bead sorting as described above.Immunity 34, 781–793, May 27, 2011 ª2011 Elsevier Inc. 791
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with a FACSDiva (BD Biosciences) cell sorter.
Analysis of Bacterial and Viral Burden
For analysis of bacterial burden after LM infection, primary or secondary
memory P14 CD8+ T cells were purified as described above and adoptively
transferred into naive recipients. The recipients and naive control mice were
infected 24 hr later with virulent LM-gp33. On day 3 postinfection, liver or
spleen samples were obtained and bacterial content was analyzed as previ-
ously described (Harty and Bevan, 1995). For analysis of viral burdens,
memory P14 CD8+ T cells were adoptively transferred as indicated. The recip-
ients and naive control mice were infected 24 hr later with LCMV Armstrong
(2 3 105, i.p.), LCMV clone 13 (2 3 106, i.v.), VacV-gp (1 3 107 i.n.), or
MHV-gp33 (1 3 105 i.n.). On the peak day of infection, the appropriate organ
was obtained and homogenized, and viral titers were quantified with standard
plaque assaying on VERO cells as previously described (Shen et al., 1998). For
VacV-gp titers, lung homogenates underwent three rounds of freeze-thaw
before being applied to VERO cells. MHV viral load was quantified as
previously described (Kim and Perlman, 2003).
In Vitro Proliferation
Spleen samples were obtained from mice containing either primary or
secondary memory P14 CD8+ T cell populations. Total splenocytes were
stained with 1 mMCFSE for 15 min and thoroughly washed with RPMI contain-
ing 10% fetal calf serum. Twomillion total splenocytes were then incubated for
60 hr with our without 50 nMgp33 peptide. Recombinant human IL-2was used
at a concentration of 100 U/ml. Proliferation was analyzed by CFSE dilution of
the Thy1.1 memory P14 CD8+ T cell population.
Ex Vivo Cytokine Production
Analysis of IFNg, TNFa, and IL-2 production by antigen-specific CD8+ T cells
was performed essentially as previously described (Badovinac et al., 2002). In
brief, 2 3 106 total splenocytes were incubated for 5 hr with or without gp33
peptide in the presence of Brefeldin A. Intracellular cytokine staining was
then performed with the BD Cytofix/Cytoperm kit in accordance to the manu-
facturer’s protocol. In cases where cytokine production was analyzed from
blood samples, 2 3 105 EL4 (H-2b) cells were added for maximizing antigen
presentation to responding T cells.
FTY720 Preparation and Treatment
FTY720 (Caymen Chemical, Ann Arbor, Michigan) was dissolved in DMSO at
a concentration of 10 mg/ml and stored at 20C. Stock solutions of
FTY720 were then diluted in sterile saline before i.v. administration at a dose
of 1 mg/kg. After LCMV clone 13 infection, mice received FTY720 treatments
on days 0, 2, 4, 6, and 8.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/j.
immuni.2011.03.020.
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